Drug intelligence / Profile preview

L03RD1

Development stage: Unknown
Lead developer: Celltrion
Modality: Small Molecules
Administration: Oral

Overview

L03RD1 is a drug developed by Celltrion. It is currently undergoing a Phase I clinical trial to evaluate its pharmacokinetics and safety in healthy volunteers. The drug is administered orally as a tablet. Its specific mechanism of action and primary indication are not yet publicly disclosed.

Beyond the preview

Go deeper on L03RD1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on L03RD1.

Explore the full profile